A Cost-Effectiveness Analysis of Palbociclib and other Aromatase Inhibitors for Treatment of Advanced Breast Cancer

被引：7
|
作者：
Bhattacharya, K. [1 ]
Yang, Y. [2 ]
机构：
[1] Univ Mississippi, Oxford, MS USA
[2] Univ Mississippi, University, MS 38677 USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1589
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN90
引用
收藏
页码：A150 / A150
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of palbociclib in hormone receptor-positive advanced breast cancer
    Mamiya, H.
    Tahara, R. K.
    Tolaney, S. M.
    Choudhry, N. K.
    Najafzadeh, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (08) : 1825 - 1831
  • [2] Cost-effectiveness and safety of palbociclib and everolimus for treating advanced and recurrent breast cancer
    Kimura, M.
    Usami, E.
    Yoshimura, T.
    [J]. PHARMAZIE, 2019, 74 (12): : 763 - 766
  • [3] REVIEW OF COST-EFFECTIVENESS STUDIES ON AROMATASE INHIBITORS FOR THE TREATMENT OF EARLY-STAGE BREAST CANCER
    Topaloglu, O.
    Unalp, A.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A38 - A38
  • [4] Review of cost-effectiveness studies on aromatase inhibitors for the treatment of early-stage breast cancer
    Topaloglu, O.
    Unalp, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practice
    da Costa, Filipa Alves
    Borges, Fabio Cardoso
    Ramos, Adriana
    Mayer, Alexandra
    Brito, Claudia
    Ramos, Catarina
    Bernardo, Catarina
    Cossito, Mariane
    Furtado, Claudia
    Ferreira, Arlindo R.
    Martins-Branco, Diogo
    Miranda, Ana da Costa
    Lourenco, Antonio
    [J]. BREAST CANCER RESEARCH, 2023, 25 (01)
  • [6] Effectiveness of palbociclib with aromatase inhibitors for the treatment of advanced breast cancer in an exposure retrospective cohort study: implications for clinical practice
    Filipa Alves da Costa
    Fábio Cardoso Borges
    Adriana Ramos
    Alexandra Mayer
    Claudia Brito
    Catarina Ramos
    Catarina Bernardo
    Mariane Cossito
    Cláudia Furtado
    Arlindo R. Ferreira
    Diogo Martins-Branco
    Ana da Costa Miranda
    António Lourenço
    [J]. Breast Cancer Research, 25
  • [7] COST-EFFECTIVENESS ANALYSIS OF PALBOCICLIB FOR THE TREATMENT OF PATIENTS WITH HR+/HER2-ADVANCED/METASTATIC BREAST CANCER IN BULGARIA
    Djambazov, S.
    Slavchev, G.
    Mitova, R.
    Velchev, M.
    Vekov, T.
    [J]. VALUE IN HEALTH, 2018, 21 : S31 - S31
  • [8] Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer
    Hashemi-Meshkini, Amir
    Keshavarz, Khosro
    Gharibnaseri, Zahra
    Kheirandish, Mehrnaz
    Kebriaeezadeh, Abbas
    Nikfar, Shekoufeh
    Abdollahi, Mohammad
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (03) : 472 - 478
  • [9] Cost-effectiveness of full coverage of aromatase inhibitors for Medicare beneficiaries with early breast cancer
    Ito, Kouta
    Elkin, Elena
    Blinder, Victoria
    Keating, Nancy
    Choudhry, Niteesh
    [J]. CANCER, 2013, 119 (13) : 2494 - 2502
  • [10] Aromatase inhibitors: Treatment of advanced breast cancer
    Panasci, LC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (19) : 3999 - 4000
12345